How Should We Measure Diversity in Clinical Trials?
At the recent Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting, I spoke about what really matters when measuring diversity in clinical trials.
After Your Cancer Diagnosis: What To Know About The Side Effects of EGFR Inhibitor Drugs
EGFR inhibitor drugs have proven to be effective in treating several types of cancers, but they can come with uncomfortable side effects. Here’s what you should know.
Encouraging and Facilitating Diverse Participation in Clinical Trials | An Empowered Patient Podcast by Karen Jagoda
Encouraging and Facilitating Diverse Participation in Clinical Trials | An Empowered Patient Podcast by Karen Jagoda
How Is Thyroid Eye Disease Diagnosed And Treated?
Thyroid eye disease (TED), also known as Graves' orbitopathy, thyroid-associated orbitopathy, or Graves’ eye disease, is an autoimmune condition that causes inflammation and swelling of the eye muscles and tissue around the eyes. This can create bulging, watery eyes, sensitivity to light, or double vision.
Embracing Diversity in Clinical Trials: 5 Key Takeaways from the SCRS Diversity Site Solutions Summit
Research sites play an important role in implementing diversity plans, reducing barriers to participation and improving patient retention with greater engagement. These were just a few important themes from the Society for Clinical Research Sites’ second Diversity Site Solutions Summit.
Racial Concordance In Clinical Trials
Research has shown racial concordance between a patient and clinician can improve trust and the patient experience. That extends to clinical trials as well.